Molecular analysis of OXA-48-producing Escherichia coli in Switzerland from 2019 to 2020.

Détails

Ressource 1Télécharger: 36103096_BIB_65F2E9192F78.pdf (1139.91 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_65F2E9192F78
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Molecular analysis of OXA-48-producing Escherichia coli in Switzerland from 2019 to 2020.
Périodique
European journal of clinical microbiology & infectious diseases
Auteur⸱e⸱s
Findlay J., Perreten V., Poirel L., Nordmann P.
ISSN
1435-4373 (Electronic)
ISSN-L
0934-9723
Statut éditorial
Publié
Date de publication
11/2022
Peer-reviewed
Oui
Volume
41
Numéro
11
Pages
1355-1360
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
OXA-48-type ß-lactamases are the most prevalent carbapenemase-type in Enterobacterales in Switzerland, predominantly found in Escherichia coli and Klebsiella pneumoniae. Bacteria-producing OXA-48-type enzymes are endemic in some parts of the world, including Europe and North Africa, and are a frequent cause of nosocomial infections. Despite the emergence of numerous OXA-48-type variants, the original variant, OXA-48, remains the most prevalent in E. coli. This study describes the epidemiology of OXA-48-producing E. coli isolates submitted to the Swiss National Reference Center for Emerging Antibiotic Resistance (NARA) between January 2019 and December 2020.
Mots-clé
Anti-Bacterial Agents/pharmacology, Anti-Bacterial Agents/therapeutic use, Bacterial Proteins, Cross Infection/drug therapy, Escherichia coli, Escherichia coli Infections/microbiology, Humans, Klebsiella Infections/microbiology, Klebsiella pneumoniae, Microbial Sensitivity Tests, Switzerland/epidemiology, beta-Lactamases/genetics, Carbapenemase, Epidemiology, OXA-48, Plasmid
Pubmed
Web of science
Open Access
Oui
Création de la notice
25/10/2022 15:47
Dernière modification de la notice
23/01/2024 8:27
Données d'usage